Schizophrenia Trial, Recruiting NCT06588270 Sponsor: Hospital de la Florida Dra. Eloiza Diaz Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06588270
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A psychiatrist has diagnosed the person with schizophrenia, confirmed using a standard international classification system (ICD-10).
  • The person is between 18 and 65 years old.
  • The person is receiving care as an outpatient (not currently staying in hospital for treatment).
  • The person has been clinically stable, meaning no psychiatric hospital admissions in the last 6 months and not currently waiting to be admitted to a psychiatric hospital.
  • The person does not have an active substance or drug misuse disorder (tobacco/nicotine use is not excluded).
  • The person is able to understand and agree to participate by giving informed consent.

Who may not be able to join:

  • The person has a previously diagnosed learning disability, based on ICD-10 criteria or their medical history.
  • The person has difficulties with verbal communication, whether due to language barriers or a medical condition.
  • The person is deaf and/or blind.
  • The person has a physical condition that would prevent them from using virtual reality (VR) devices.
  • The person is currently experiencing predominantly positive symptoms of schizophrenia, as measured by a specific clinical scale (PANSS-C score above 0) (confirm with trial site).
  • The person has catatonic symptoms (episodes of abnormal movement or unresponsiveness linked to their condition).
  • The person has a previous diagnosis of epilepsy.
  • The person has a neurodegenerative disease (a condition involving progressive loss of nerve function, such as Parkinson's or Alzheimer's disease).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +569654112870

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital de la Florida Dra. Eloiza Diaz
Registry
ClinicalTrials.gov
Start date
2 May 2022
Est. completion
1 May 2025

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Negative symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov